Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.31+0.17 (+7.94%)
Close on Nov 18, 2026Market cap $39.39MP/E –Yield –
Veru revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Veru's revenue for the twelve months ending Sep 30, 2024 was $16.89M, up 3.6% year over year. For fiscal 2024 it was $16.89M, up 3.6% from the year before. Over ten years it grew -3.6% a year on average. The highest annual figure on record is $61.26M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | $16.89M | +3.6% |
| FY2023 | Sep 30, 2023 | $16.30M | -58.6% |
| FY2022 | Sep 30, 2022 | $39.35M | -35.8% |
| FY2021 | Sep 30, 2021 | $61.26M | +43.8% |
| FY2020 | Sep 30, 2020 | $42.59M | +33.9% |
| FY2019 | Sep 30, 2019 | $31.80M | +100.5% |
| FY2018 | Sep 30, 2018 | $15.86M | +16.2% |
| FY2017 | Sep 30, 2017 | $13.66M | -38.3% |
| FY2016 | Sep 30, 2016 | $22.13M | -32.1% |
| FY2015 | Sep 30, 2015 | $32.60M | +33.1% |
| FY2014 | Sep 30, 2014 | $24.49M | -22.1% |
| FY2013 | Sep 30, 2013 | $31.46M | -10.2% |
| FY2012 | Sep 30, 2012 | $35.03M | +188609.9% |
| FY2011 | Sep 30, 2011 | $18.57K | -99.9% |
| FY2010 | Sep 30, 2010 | $22.22M | -19.3% |
| FY2009 | Sep 30, 2009 | $27.54M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $0 | -100.0% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $6.66M | +72.4% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $3.95M | +18.3% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $4.14M | -37.2% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $2.14M | -14.6% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $3.86M | +49.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $3.34M | -65.2% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $6.59M | -49.4% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $2.51M | -82.3% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $2.59M | -83.5% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $9.60M | -45.6% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $13.03M | -2.3% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $14.14M | -3.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $15.65M | +33.2% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $17.66M | +71.1% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $13.34M | +34.2% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $14.62M | +38.2% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $11.75M | +34.6% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $10.32M | +6.1% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $9.94M | +42.5% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $10.58M | +66.0% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $8.73M | +67.7% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $9.73M | +76.8% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $6.98M | +171.1% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $6.37M | +146.3% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $5.20M | +40.9% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $5.50M | +27.5% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $2.57M | +7.0% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $2.59M | -20.3% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $3.69M | +3.6% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $4.31M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $2.41M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $3.24M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $3.56M | – |
See a number that looks wrong?